SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
10969972
Source:
http://linkedlifedata.com/resource/pubmed/id/10969972
Search
Subject
(
63
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0036085
,
umls-concept:C0243076
,
umls-concept:C0303231
,
umls-concept:C0439836
,
umls-concept:C0531375
,
umls-concept:C1708373
,
umls-concept:C1762617
,
umls-concept:C1854310
pubmed:issue
16
pubmed:dateCreated
2000-12-6
pubmed:abstractText
A weak HTS hit at the CCR2B receptor has been converted into a potent antagonist by array SAR studies. Selectivity over the closely related CCR5 receptor is also achieved.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9107377
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Amides
,
http://linkedlifedata.com/resource/pubmed/chemical/CCR2 protein, human
,
http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CCL2
,
http://linkedlifedata.com/resource/pubmed/chemical/Indoles
,
http://linkedlifedata.com/resource/pubmed/chemical/Ligands
,
http://linkedlifedata.com/resource/pubmed/chemical/Piperidines
,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, CCR2
,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, CCR5
,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Chemokine
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0960-894X
pubmed:author
pubmed-author:BerkhoutT ATA
,
pubmed-author:CooperD GDG
,
pubmed-author:DoddsE KEK
,
pubmed-author:ForbesI TIT
,
pubmed-author:GohilJJ
,
pubmed-author:GrootP HPH
,
pubmed-author:HickeyD MDM
,
pubmed-author:IfeR JRJ
,
pubmed-author:MeesonMM
,
pubmed-author:MooresKK
,
pubmed-author:StockleyMM
pubmed:issnType
Print
pubmed:day
21
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1803-6
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:10969972-Amides
,
pubmed-meshheading:10969972-Chemokine CCL2
,
pubmed-meshheading:10969972-Chemotaxis, Leukocyte
,
pubmed-meshheading:10969972-Humans
,
pubmed-meshheading:10969972-Indoles
,
pubmed-meshheading:10969972-Kinetics
,
pubmed-meshheading:10969972-Ligands
,
pubmed-meshheading:10969972-Molecular Structure
,
pubmed-meshheading:10969972-Monocytes
,
pubmed-meshheading:10969972-Piperidines
,
pubmed-meshheading:10969972-Receptors, CCR2
,
pubmed-meshheading:10969972-Receptors, CCR5
,
pubmed-meshheading:10969972-Receptors, Chemokine
,
pubmed-meshheading:10969972-Structure-Activity Relationship
pubmed:year
2000
pubmed:articleTitle
CCR2B receptor antagonists: conversion of a weak HTS hit to a potent lead compound.
pubmed:affiliation
Department of Discovery Chemistry, SmithKline Beecham Pharmaceuticals, Harlow, Essex, UK. ian_t_forbes@sbphrd.com
pubmed:publicationType
Journal Article